Making the Future Better for All of Us
Dr. Yvonne Chiu is making important progress in morphea research that directly helps care for pediatric dermatology patients. She shared more about her work, the important role of mentorship, and how an early vote of confidence she received from the Dermatology Foundation made a difference in her career. She also has some exciting thoughts on the future of our specialty.
Research in Practice, Changing Lives
Eleni Linos M.D., M.P.H., DrPH, is Professor of Dermatology and Epidemiology at Stanford University. Among her many research projects, her current work is having an immediate impact on public health during the pandemic. As an active mentor to younger investigators, she shared with us her vision for the future and why she believes that the “intersection of public health and dermatology is a huge opportunity to positively impact people’s lives.”
The Top 5 Reasons I Support the Dermatology Foundation
Stuart R. Lessin, M.D. serves as KGL Skin Study Center’s Medical Director and is a DF Fitzpatrick Legacy Fund member. He has over 30 years of laboratory and clinical research experience including topical drug development and testing. Dr. Lessin recently spoke with us about a few of the reasons he’s involved with the Dermatology Foundation and has found it to be such a significant organization in his life for so long.
Supporting Research, Saving Lives
Dr. Karen Connolly has been a Dermatology Foundation member since she landed her first job. As a busy surgical dermatologist, she’s been impressed with the type of cutting-edge research the DF funds and by their ongoing educational offerings — just one of the reasons she’s such an advocate for this organization. As she says in this interview: “To support residents, to support education — that’s so important.”
Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia
Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather than chronic inflammation is the ongoing dominant response. This study…
Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus
Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant decrease in quality of life. Little is known about the…
Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy
Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent upon treatment discontinuation. Our clinical observations suggest long-term remission for…
Characterizing the Role of the Cutaneous Microbiota in Darier Disease
Darier disease is an inherited disorder of acantholytic dyskeratosis. Lesions are most prominent on seborrheic skin and are prone to secondary infections, which lead to disease flares and significant morbidity….
Immunoediting in Cutaneous Squamous Carcinogenesis
Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer, with ~700,000 cases, ~3,000 deaths, and billions of dollars in annual treatment-associated costs in the U.S. Escape from immunosurveillance,…
Assessing the Functional Consequences of Mitochondrial Genomic Alterations in Cutaneous Aging
Mitochondria generate energy for cells. They contain their own genome, which supports their function. Photoaging is associated with alterations to this genome, but the effects of these changes on mitochondrial…